A leading diagnostic company wanted an assessment of the future market landscape for low-throughput (LT) molecular diagnostic (MDx) testing to develop a long-term platform strategy to address the future needs of this market
Secondary Research
Primary Research
Quantitative Analysis
23 weeks
Global
Clinical Diagnostics
Voice-Of-Customer Research
Product Performance and Specification Mapping
Biomarker and Diagnostic Strategy
Competitive Analysis
Addressable Market Sizing
Customer Segmentation